Difference between revisions of "Regimen classes"
Jump to navigation
Jump to search
m (→Chemotherapy) |
|||
| Line 25: | Line 25: | ||
==Anti-CD20-based regimen== | ==Anti-CD20-based regimen== | ||
===Rituximab-containing regimen=== | ===Rituximab-containing regimen=== | ||
| + | ====R-CHOP-like therapy==== | ||
==Anti-HER2-based regimen== | ==Anti-HER2-based regimen== | ||
Revision as of 11:59, 24 September 2022
The purpose of this page is to define regimen classes that will be used in the HemOnc ontology; it is not for other purposes at this time.